ReviewBiomolecules2025
Female Reproductive Tract Organoids: Applications from Physiology to Pathology.
Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The Role of Macrophages in Endometrial Cyclical Changes and Female Reproductive System Diseases: A Review.Current issues in molecular biology · 2026Review
- Three-Dimensional Organoid-like Co-Culture of Human Endometrial Endothelial and Stromal Cells to Study Endometriosis-Associated Responses.International journal of molecular sciences · 2026Article
- Organoids for disease modeling and treatment: state-of-the-art.Experimental hematology & oncology · 2026Review
- Maternal-fetal interface organoids: a new era in pregnancy research.Frontiers in bioengineering and biotechnology · 2026Review
- Human fallopian tube organoids: Bridging fertility research, education, and health policy.Journal of education and health promotion · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The female reproductive tract (FRT) serves as the core of human reproduction, and its health is directly related to population quantity and family happiness. The high incidence rate of female reproductive tract diseases globally poses a severe threat to women's health. Nevertheless, the exploration of its physiological functions and pathological mechanisms still lacks satisfactory research models. Organoids, as an emerging technology, not only circumvent numerous ethical issues existing in in vivo experiments but also precisely replicate the morphological structure and characteristics of the simulated tissues. The purpose of this article is to summarize the basic paradigms of organoid establishment and their applications in female reproductive research. Specifically, this article summarizes the cell sources, extracellular scaffolds, and culture media used in the establishment of organoids. It also describes the applications and future development prospects of female reproductive tract organoids established in current research in physiological and pathological studies. The importance of organoid technology in the female reproductive tract research cannot be ignored. It has opened up new avenues for research in this field and greatly promoted the exploration of female reproductive health and disease mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.